$CUE SEC Filings

Filed On	Filing
14 Oct 2026	Form 4: Meluzio Michael Vincent, VP, Prin. Accounting Officer Sold 1,144 shares ($32.1K)
14 Oct 2026	Form 4: Lin Shao-Lee, Director Sold 11,087 shares ($305K)
14 Oct 2026	Form 4: Ray Sumita, Chief Legal Compliance Officer Sold 1,844 shares ($51.7K)
13 Oct 2026	144
13 Oct 2026	144
08 Oct 2026	SCHEDULE 13G/A
21 Sep 2026	8-K: Regulation FD Disclosure; Other Events Results support potential for differentiated clinical impact for patients suffering from chronic
28 Aug 2026	Form 4/A: Sarraf Pasha, Director Received 18,400 shares as a grant or award
28 Aug 2026	Form 4/A: Garzone Pamela, Director Received 18,900 shares as a grant or award
21 Aug 2026	SCHEDULE 13D
20 Aug 2026	EFFECT
18 Aug 2026	CORRESP
17 Aug 2026	UPLOAD
17 Aug 2026	Form 4: Ray Sumita, Chief Legal Compliance Officer Received 18,196 shares by exercise or conversion · Sold 8,829 shares ($266K)
17 Aug 2026	Form 4: Meluzio Michael Vincent, VP, Prin. Accounting Officer Received 13,647 shares by exercise or conversion · Sold 5,628 shares ($169K)
14 Aug 2026	Form 4: Lin Shao-Lee, Director Received 109,179 shares by exercise or conversion · Sold 40,000 shares ($1.08M) · Sold 18,258 shares ($523K)
14 Aug 2026	144
14 Aug 2026	SCHEDULE 13G
14 Aug 2026	10-Q
14 Aug 2026	8-K: Results of Operations and Financial Condition

Comments